Ítem
Solo Metadatos
PCN87 Economic Evaluation of Sunitinib as First-Line Treatment for Metastatic Renal Cell Carcinoma in Colombia
Título de la revista
Autores
Prieto, VA
Reyes, JM
Lopez-Cabra, C
Diaz, JA
Urrego-Novoa
Fecha
2016-05-01
Directores
ISSN de la revista
Título del volumen
Editor
Elsevier
Citations
Métricas alternativas
Resumen
Abstract
To estimate the cost-effectiveness of sunitinib as first-line treatment for metastatic renal-cell carcinoma (mRCC) from the Colombian health system perspective.
Palabras clave
Keywords
Public Health and Health Services , Medical and Health Sciences , Applied Economics , Economics
Citations
Enlace a la fuente
https://www.valueinhealthjournal.com/article/S1098-3015(16)01654-5/fulltext?_returnURL=https%3A%2F%2Flinkinghub.elsevier.com%2Fretrieve%2Fpii%2FS1098301516016545%3Fshowall%3Dtrue
